Catherine Blanc
28 Rue Du Dr. Roux
Paris, 75015, France
Paris, 75015, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Eradication of pre-clinical prostate tumors by a lentiviral vector-based immunotherapy.
Journal: Molecular therapy. Oncology
Published: March 09, 2026
Temperature-dependent replication and sensitivity to innate immunity of human coronavirus HKU1.
Journal: Nature communications
Published: November 07, 2025
Lentiviral vector-based T-cell vaccines against Zika and yellow fever viruses.
Journal: Vaccine
Published: April 23, 2025
A lentiviral vector targeting a KRAS neoepitope for cancer immunotherapy.
Journal: Scientific reports
Published: March 17, 2025
Optimized lentiviral backbone induces robust and diverse T cell immunity against neoantigens to counteract tumor heterogeneity.
Journal: NPJ vaccines
Published: February 21, 2025
Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus.
Journal: Cell
Published: February 14, 2024
T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.
Journal: NPJ vaccines
Published: November 30, 2023
Preclinical proof of concept of a tetravalent lentiviral T-cell vaccine against dengue viruses.
Journal: Frontiers in immunology
Published: April 18, 2023
TMPRSS2 is a functional receptor for human coronavirus HKU1.
Journal: Nature
Published: April 07, 2023
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.
Journal: EMBO molecular medicine
Published: March 20, 2023
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 13, 2022
Last Updated: 09/26/2026